Tom Rawlings »

Biosante Pharmaceuticals shares owned by Tom Rawlings

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Tom Rawlings from 13F filings

Historical chart of Tom Rawlings investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Tom Rawlings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Tom Rawlings

Quarter filed Position value Share count Share price at filing
2022-12-31 $1.4M 35k 40.23

More positions owned by Tom Rawlings

Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Bank of America Corporation (BAC)
Thermo Fisher Scientific (TMO)
ConocoPhillips (COP)
Alphabet Cap Stk Cl A (GOOGL)
UnitedHealth (UNH)
Charles Schwab Corporation (SCHW)
Schlumberger Com Stk (SLB)
Quanta Services (PWR)
Northrop Grumman Corporation (NOC)
Duke Energy Corp Com New (DUK)
Bristol Myers Squibb (BMY)
BlackRock (BLK)
Hartford Financial Services (HIG)

View all positions for Tom Rawlings

Top funds holding Biosante Pharmaceuticals

Vanguard Group
Dimensional Fund Advisors
Global Alpha Capital Management
William Blair Investment Management
Kennedy Capital Management
Jpmorgan Chase & Co
Thompson, Siegel, & Walmsley
Citadel Advisors
Charles Schwab Investment Management
Brandywine Global Investment Management
Bank of New York Mellon
Russell Investments
Principal Financial Group
Marathon Capital Management
Hillsdale Investment Management

View all funds holding Biosante Pharmaceuticals